At a CAGR of 18.07%, Global Cancer Diagnostics Device Market 2016-2020, Market Analysis, Reimbursement Structure and Industry Overview Report

Global Cancer Diagnostics Device Market 2016-2020 Size and Share Published in 2016-06-13 Available for US$ 2500 at


About the Cancer Diagnostic Devices Market

An increase in any particular internal and external factor can lead to cancer. Currently, the demand for cancer therapy and research in complex molecular tumor diagnostics is high. Researchers are using automated solutions to isolate genetic materials from small tissue samples. The complex genetic analysis of samples using next-generation sequencing technologies helps researchers analyze the individual and relevant pattern of genetic changes in tumor tissues, helping in determining the most effective treatment options.

The development of sophisticated technologies such as microarray, next-generation sequencing, mass spectrometry, automated DNA sequencing, fluorescence in-situ hybridization, and comparative genomic hybridization has opened new avenues for cancer biomarkers. These technologies are capable of detecting abnormalities in the gene expression and the genetic structure of cancer cells. In addition, these technologies can analyze changes in the DNA, RNA, and chromosomes from tissue samples of a tumor.

Technavios analysts forecast the global cancer diagnostics devices market to grow at a CAGR of 18.07% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global cancer diagnostics devices market for 2016-2020 To calculate the market size, we consider revenue generated from the sales of molecular and companion cancer diagnostic devices.

The market is divided into the following segments based on geography:




Technavio’s report, Global Cancer Diagnostics Devices Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

Abbott Diagnostics

Agilent Technologies




Roche Diagnostics

Get a Sample Copy of the Report:

Other prominent vendors


Ambry Genetics


Aviva Biosciences



Cancer Genetics




Epic Sciences


Genomic Health




Myriad Genetics

Thermo Fisher Scientific

Ventana Medical Systems


Market driver

Demand for personalized medicines

For a full, detailed list, view our report

Market challenge

High cost of developing companion diagnostics

For a full, detailed list, view our report

Market trend

Demand for personalized medicines

For a full, detailed list, view our report

Key questions answered in this report

What will the market size be in 2020 and what will the growth rate be?

What are the key market trends?

What is driving this market?

What are the challenges to market growth?

Who are the key vendors in this market space?

What are the market opportunities and threats faced by the key vendors?

What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.

Inquiry on this report:

Table of Content

PART 01: Executive summary


PART 02: Scope of the report

Market overview

Top-vendor offerings

PART 03: Market research methodology

Research methodology

Economic indicators

PART 04: Introduction

Key market highlights

PART 05: Cancer statistics

PART 06: Market landscape

Market overview

Market size and forecast

Five forces analysis

PART 07: Reimbursement and coverage: An overview

Current scenario: Validating diagnostic tests

Reimbursement structure in US

Reimbursement structure in EU

Browse All Healthcare Market Research Reports at:

About ResearchMoz

ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives.

Contact Us:

Mr. Nachiket Ghumare, +1-518-621-2074
USA-Canada Toll Free: 866-997-4948



Leave a Reply

Designed by
Powered by